Grover Sandeep, Sahoo Swapnajeet
Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Pharmacol. 2015 Mar-Apr;47(2):234-5. doi: 10.4103/0253-7613.153441.
Clozapine is a second-generation antipsychotic medication, which is mostly used in patients with treatment resistant schizophrenia. It is considered to be associated with lower incidence of extrapyramidal side-effects. Akathisia is considered to be a rare side-effect of clozapine. In this report, we describe a patient who developed akathisia while receiving clozapine and review the literature. Existing literature suggests that except for few initial reports, data suggests that clozapine is in general associated with lower incidence of akathisia compared to first generation antipsychotics. Data comparing clozapine with other atypical antipsychotics is equivocal.
氯氮平是一种第二代抗精神病药物,主要用于治疗难治性精神分裂症患者。它被认为与锥体外系副作用的发生率较低有关。静坐不能被认为是氯氮平的一种罕见副作用。在本报告中,我们描述了一名在接受氯氮平治疗时出现静坐不能的患者,并对相关文献进行了综述。现有文献表明,除了少数早期报告外,数据显示与第一代抗精神病药物相比,氯氮平总体上与静坐不能的发生率较低有关。比较氯氮平与其他非典型抗精神病药物的数据并不明确。